Microbix Biosystems Inc.
TSX : MBX

Microbix Biosystems Inc.

May 27, 2015 08:28 ET

Microbix Invited to Present at 2015 LD Micro Investor Conference

TORONTO, ONTARIO--(Marketwired - May 27, 2015) - Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that its Chief Executive Officer, Vaughn Embro-Pantalony, will present an update of the Company's business at the 2015 LD Micro Invitational Conference on Wednesday, June 3, 2015 at 8:00 a.m. Pacific Time. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Mr. Embro-Pantalony's presentation will be webcast live and archived for at least 90 days on the Company's website at http://www.microbix.com under the "Events" listing in the Investors section.

About LD Micro

LD Micro publishes an online investment newsletter that provides self-directed investors with information on selected public companies in North America that, in the opinion of LD Micro, have strong investment potential. LD Micro is a non-registered investment advisor. Since 2008, LD Micro has been hosting private investor conferences where target companies are invited to present. This year 185 companies will be presenting, with over 1,000 people participating.

About Microbix Biosystems Inc.

Microbix specializes in the research and development of biological solutions, including human health products for vaccine, therapeutic and diagnostic global markets, as well as animal reproductive markets worldwide. The Company manufactures and distributes a wide range of infectious disease antigens to a global customer base. Microbix' pipeline of innovative technologies and products includes LumiSort™, a semen sexing technology for the livestock industries; Kinlytic®, a thrombolytic drug with several approved and potential applications including the treatment of life-threatening blood clots; and VIRUSMAX®, a proprietary technology for increasing virus yields in the manufacture of influenza vaccine. Established in 1988, Microbix is based in Mississauga, Ontario and is listed on the Toronto Stock Exchange under the trading symbol 'MBX'.

Forward-Looking Information

This news release includes "forward-looking information", as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, the risks associated with development projects, operations in foreign jurisdictions, risks associated with engineering and construction generally, risks associated with production including control over costs, quality, quantity and timeliness of delivery of products, foreign currency and exchange rate risk, and risks of raising capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company's judgment as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please visit www.sedar.com for recent Microbix Biosystems Inc. filings.

Contact Information